- Product name: RAPID SARS-COV-2 ANTIGEN TEST CARD
- Specimen: Nasopharyngeal Swab specimens
- Test Time: 15-20 Minutes
- Shelf Life: 18 Months
- Storage Temperature: Room Temperature
We offer competitive shipping rates calculated at checkout!
Choose from a wide variety of carriers shipping all across Canada.
- Rapid SARS-CoV-2 Antigen Test Card - 20 UNITS
- Sterilized swab - 20 UNITS
- Extraction tube - 20 UNITS & tube rack - 1 UNIT
- Sample extraction buffer - 2 UNITS (4 mL each)
- Instructions for use - 1 UNIT
Returns & Refund Policy
Easy to use: Nasopharyngeal swab test kits with easy to use instructions.
Quick and efficient: get your rapid test results in as little as 15 minutes!
Affordable pricing: our tests are available for as low as $2.50/test — one of the most competitive prices on the Canadian market!
These tests are recommended for use by qualified healthcare professionals.
US Customers: these tests are approved for sale in Canada only. For tests approved for sale in the USA, please visit our US store here.
Authorized by Health Canada
Easy to Follow Instructions
Quick and Accurate Results
Priority Shipping Available
View Our Detailed Product Description
BOSON COVID-19 Rapid Antigen Test is a rapid and convenient immunochromatographic assay for the qualitative detection of COVID-19 antigen (viral nucleoprotein) from nasopharyngeal swab obtained from patients with signs and symptoms of respiratory infection. The device is designed to aid in the rapid diagnosis of COVID-19 Virus infection.
Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigens are generally detectable in nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities.
Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management.
Pursuant to section 5 of the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19, made by the Minister of Health on March 18, 2020, the BOSON COVID-19 Rapid Antigen Test is now authorized for sale or importation in Canada. Authorization Ref Number: 323096